Damora Therapeutics, Inc. DMRA
NASDAQ · United States · Health Technology
$20.51-0.78 (-3.64%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -0.39 | -0.41 | +5.1% | $0 | — | +1.5%$29.92→$30.36 |
| Q1 2026 | 2026-05-12 | -0.62 | -0.21 | -195.2% | — | — | -0.8%$24.36→$24.16 |
| Q4 2024 | 2025-03-19 | -5.00 | -2.82 | -77.3% | — | — | — |
| Q3 2024 | 2024-11-01 | -3.39 | -3.70 | +8.4% | — | — | — |
| Q2 2024 | 2024-08-12 | -5.00 | -6.00 | +16.7% | — | — | — |
| Q1 2024 | 2024-04-29 | -5.00 | -4.25 | -17.6% | — | — | — |
| Q4 2023 | 2024-03-08 | -4.76 | -6.25 | +23.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.